ORAL-CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE AMONG PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN

被引：21
|
作者：
BERKOWITZ, GS
KELSEY, JL
LIVOLSI, VA
HOLFORD, TR
MERINO, MJ
ORT, S
OCONNOR, TZ
GOLDENBERG, IS
WHITE, C
机构：
[1] YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510
[3] YALE UNIV,SCH MED,DEPT SURG,NEW HAVEN,CT 06510
[4] MT SINAI MED CTR,DEPT COMMUNITY MED,NEW YORK,NY 10029
[5] COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY 10027
[6] UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104
[7] YALE UNIV,SCH MED,CTR CHILD STUDY,NEW HAVEN,CT 06510
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 1984年 / 120卷 / 01期
关键词：
D O I：
10.1093/oxfordjournals.aje.a113878
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：87 / 96
页数：10
相关论文
共 50 条
  • [1] ORAL-CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE OF DIFFERENT HISTOLOGIC CLASSIFICATIONS
    HSIEH, CC
    CROSSON, AW
    WALKER, AM
    TRAPIDO, EJ
    MACMAHON, B
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1984, 72 (02) : 285 - 290
  • [2] THE EFFECT OF ORAL-CONTRACEPTIVE USE ON VERTEBRAL BONE MASS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
    LINDSAY, R
    TOHME, J
    KANDERS, B
    CONTRACEPTION, 1986, 34 (04) : 333 - 340
  • [3] ORAL-CONTRACEPTIVE USE AND FIBROCYSTIC BREAST DISEASE WITH SPECIAL REFERENCE TO ITS HISTOPATHOLOGY
    PASTIDES, H
    KELSEY, JL
    LIVOLSI, VA
    HOLFORD, TR
    FISCHER, DB
    GOLDENBERG, IS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1983, 71 (01) : 5 - 9
  • [4] BREAST-CANCER AND ORAL-CONTRACEPTIVE THERAPY IN PREMENOPAUSAL WOMEN
    GAMBRELL, RD
    MASSEY, FM
    CASTANEDA, TA
    BODDIE, AW
    JOURNAL OF REPRODUCTIVE MEDICINE, 1979, 23 (06) : 265 - 271
  • [5] EFFECTS OF ORAL-CONTRACEPTIVE AND ESTROGEN ADMINISTRATION ON PLASMA CALCITONIN IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
    HURLEY, DL
    TIEGS, RD
    BARTA, J
    LAAKSO, K
    HEATH, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 1989, 4 (01) : 89 - 95
  • [6] BENIGN BREAST DISEASE AND ORAL-CONTRACEPTIVE USE
    JANERICH, DT
    GLEBATIS, DM
    DUGAN, JM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (20): : 2199 - 2201
  • [7] FIBROCYSTIC BREAST DISEASE IN ORAL-CONTRACEPTIVE USERS - HISTOPATHOLOGICAL EVALUATION OF EPITHELIAL ATYPIA
    LIVOLSI, VA
    STADEL, BV
    KELSEY, JL
    HOLFORD, TR
    WHITE, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (08): : 381 - 385
  • [8] ORAL-CONTRACEPTIVE CONTAINING NATURAL ESTRADIOL FOR PREMENOPAUSAL WOMEN
    HIRVONEN, E
    ALLONEN, H
    ANTTILA, M
    KULMALA, Y
    RANTA, T
    RAUTIAINEN, H
    SIPILA, P
    YLOSTALO, P
    MATURITAS, 1995, 21 (01) : 27 - 32
  • [9] EARLY ORAL-CONTRACEPTIVE USE AND BREAST-CANCER AMONG PREMENOPAUSAL WOMEN - FINAL REPORT FROM A STUDY IN SOUTHERN SWEDEN
    OLSSON, H
    MOLLER, TR
    RANSTAM, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (13) : 1000 - 1004
  • [10] EXOGENOUS HORMONE USE AND FIBROCYSTIC BREAST DISEASE AMONG PREMENOPAUSAL AND POST-MENOPAUSAL WOMEN
    BERKOWITZ, G
    KELSEY, J
    HOLFORD, T
    LIVOLSI, V
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 118 (03) : 416 - 417
12345